Naloxone: Prescribing and Dispensing

Slides:



Advertisements
Similar presentations
Daliah Heller, PhD, MPH Assistant Commissioner
Advertisements

Education and Training Module for Ohio EMS Developed in the 1960s Opioid antagonist Emergent overdose treatment in the hospital and prehospital settings.
2014 EMR Naloxone Presentation DPH/EMS Program Wisconsin Department of Health Services Naloxone Intranasal Administration in the Pre-hospital Setting –
Deaths Avoided With Naloxone What is Naloxone? Naloxone commonly known as Narcan is a medication that can reverse and overdose caused by an opioid drug.
Opioid Overdose Prevention for Law Enforcement and First Responders Sponsored by the NC Office of EMS.
Naloxone formulation update
Option D1 Pharmaceutical Products.  Generally a drug or medicine is any chemical (natural or man made), which does one or more of the following:  Alters.
Opioid Rescue Kits for Porter County Sheriff’s Department.
Step 1: Get Help Call 911 Tell them you have a friend who is not breathing. Make sure EMS has a clear path to get to you, and doors are unlocked. Give.
STATEWIDE OPIOID ANTAGONIST COMMUNITY ACCESS PROGRAM INTRANASAL NALOXONE ADMINISTRATION TRAINING MODULE Vermont Statewide Opioid Antagonist Program.
Opioid Antagonist Scope of Practice Modification
Opioid Safety Phillip Coffin, MD, MIA Director of Substance Use Research San Francisco Dept. of Public Health Assistant Clinical Professor University of.
Northeast Tennessee Naloxone Pilot David Kirschke, MD Medical Director Northeast Region Health Office.
Naloxone Training Program EMR/EMT May 27, 2014
SILVER CROSS EMSS EMD CE September Heroin use is increasing, and so are heroin-related overdose deaths.
Recognizing an Overdose (and Knowing How to Help) Public Curricula – Essential Knowledge for Families and Communities Core.
Naloxone (Narcan) A true opioid overdose antidote.
Recommendations on the Management of Opioid Overdose Ruth Birgin.
1-800-DIABETES DIABETES CARE TASKS AT SCHOOL: What Key Personnel Need to Know DIABETES CARE TASKS AT SCHOOL: What Key Personnel Need to.
Prepared by : Areen Zraikah Dana Fatayer. Pharmacology: Naloxone and nalmefene are pure opioid antagonists that competitively block mu, kappa, and delta.
CMT Training The Center for Life Enrichment Resource: MTTP Student Manual,
Responsibilities and Principles of Drug Administration
Combating the Opioid Abuse Epidemic with Evzio ® (naloxone) Baely Crockett, PharmD Eskenazi Health Internal Medicine PGY2 This speaker has no actual or.
Dispensing to in and out patients or Drug distribution system
Naloxone use Objectives  In this slide set, you will learn: What naloxone (Narcan) is How it works when administered to a person who has overdosed on.
Assembly Bill #2609 Health and Safety Code Effective January 1,2008 MEDICATION TRAINING FOR DIRECT CARE STAFF.
MBEMSC /PIER Committee
Grampian Naloxone Programme
There may be a title here that come from the foundation.
NALOXONE Presented by The RASE Project. Scope Of The Problem Opiate overdose is a major public health problem in the United States. Overdoses have increased.
Maryland Overdose Response Program Educational Training Program CORE CURRICULUM CONDENSED Behavioral Health Administration Department of Health & Mental.
First Responder Naloxone Grant Webinar
Naloxone for Entities & Laysavers Aaron Kochar, J.D.
Daniel Wermeling, Pharm.D. Professor, College of Pharmacy University of Kentucky.
Education and Training Module for Ohio EMS – Version 2.0.
NALOXONE (NARCAN) ADMINISTRATION.  What are opioids?  Who abuses them?  What will an overdose look like?  What is the treatment for opioid overdose?
Naloxone: Saving Lives Cathy Oliphant, PharmD Associate Professor of Pharmacy Practice ISU College of Pharmacy.
Addressing Tobacco Use in Mental Health Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester.
Addressing Tobacco Use in Medical Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester School.
Naloxone Narcan®.
Naloxone use Objectives  In this slide set, you will learn: What naloxone (Narcan) is How it works when administered to a person who has overdosed on.
Gregory S. Brigham, Ph.D., CEO
Pharmacist Role in Naloxone Prescribing
or you can use Text Voting by texting ”nmpha” to 22333
Narcan.
Medication Dosage and Administration
Unit 3 Lesson 5 General Pharmacology for ALS
Narcan? You can!: A Legislative & Clinical Update on naloxone
The Opioid Epidemic and Naloxone CTSMA 57th Annual Conference
Key Features of the UCLHguide
Opioid Overdose Responder Training
Risk evaluation and mitigation for use of opioids in chronic pain
Medication order entry & Fill process
Buccal/ Nasal Midazolam
Wicomico County Local Behavioral Health Authority
Grampian Naloxone Programme
Introduction to Clinical Pharmacology Chapter 16 Opioid Antagonists
Grays Harbor EMS & Trauma Care Council October 2016
Distributing Naloxone in the Emergency Department
QC Harm Reduction Opioid Overdose Reversal Training
Background Cancers are among the leading causes of morbidity and mortality worldwide, responsible for 18.1 million new cases and 9.6 million deaths in.
EMT Naloxone Administration
Grampian Naloxone Programme
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Naloxone (Narcan) Induced Pulmonary Edema
QC Harm Reduction Opioid Overdose Reversal Training
Introduction to Clinical Pharmacology Chapter 16 Opioid Antagonists
Medication Assisted Treatment of Opioid Use Disorder
Parenteral Dosages Chapter 12
OVERDOSE AWARENESS & NALOXONE TRAIN THE TRAINER
Presentation transcript:

Naloxone: Prescribing and Dispensing Audrey Kivlehan Student Pharmacist, Northeastern University Kivlehan.a@husky.neu.edu

Contents Introduction: What is Naloxone? Benefits and Barriers of Naloxone Use Basic Pharmacology Routes of Administration Injection Nasal Patient Population and Education Adverse Reactions Contents

Objectives After this course you will: Be able to weigh the positives and negatives of prescribing naloxone to a patient Have a basic understanding of the drug including its basic pharmacology and medicinal chemistry Understand the routes of administration available for naloxone and decide on one that best fits your patients needs Be able to educate your patient and their family members on the use of the drug and warn them of any adverse reactions Objectives

Naloxone only works to combat opioid overdose! Naloxone hydrochloride (Narcan) is a prescription medication that is indicated to reverse opioid depression in an overdose or postoperatively Naloxone only works to combat opioid overdose! This medication has been a source of controversy, however with safe prescribing, dispensing and counseling naloxone can be a treatment that addresses the opioid overdose epidemic in the USA In the United States, 100 people die from overdoses a day In 2011, of the 22,810 deaths related to pharmaceutical overdoses, 74% were due to opioid analgesics What is Naloxone?

Benefits and Barriers Benefits of Naloxone Use: Potential Barriers: Family members can use this drug to administer life-saving treatment for patients before emergency assistance arrives Naloxone availability may reduce opioid overdose in conjunction with education and counseling Potential Barriers: Stigma Patients may feel judged by physician or fear that their opioid medications may be affected Physicians may be fearful of scaring patient away or encouraging risky behavior Costly price The new auto injector (Evzio) runs around $250 per shot Benefits and Barriers

Basic Pharmacology Basic Pharmacology: Structure: Naloxone is an opioid antagonist that competes competitively with the opioid at the mu receptor Naloxone has higher affinity for the receptor and will replace the opioid Structure: Naloxone is a synthetic congener of oxymorphone oxymorphone naloxone Basic Pharmacology

Routes of Administration and Dosage Forms Injectable Intravenous Intramuscular Subcutaneous (0.4mg/1ml) Available as: Multi-dose vials (0.4mg/mL or 1mg/mL) Preservative free ampules (0.02mg/mL, 0.4mg/mL,or 1mg/mL) Nasally Intranasal kit (2.0mg/2ml) 2 mL pre-filled needleless syringe Intranasal mucosal atomizing device Always prescribe and dispense two doses of the drug Naloxone will not work after two doses have been administered Routes of Administration and Dosage Forms

Injectables Prescribing: Instructions for Use: Storage Conditions: The auto-injector (Evzio) has voice guided tutorial Patients need the vial and corresponding intramuscular needle for use Instructions for Use: Inject 1mL of naloxone into muscle Administer a second dose after 2 to 3 minutes if necessary Storage Conditions: Protect vial from light Injectables

Intranasal Prescribing: Instructions for Use: Patients need the prefilled syringe and corresponding nasal atomizer for use Instructions for Use: Tilt head back and spray 1mL into each nostril Administer a second dose after 3 to 5 minutes if necessary Intranasal

Patient Population and Education Who should be prescribed naloxone? Patients at risk for opioid overdose Patients who have someone who may access the opioid medications inappropriately (ex: children) Patient Education: Instruct patient and those who may be administering the drug to practice assembling the materials and demonstrate rescue breathing Warn patient that the drug will not help after two doses Naloxone only lasts between 30 to 90 minutes and depression may reoccur afterwards Seek immediate medical attention Patients may experience withdrawal symptoms after use Patient Population and Education

Adverse Reactions Potential Adverse Reactions: Nausea Vomiting Sweating Tachycardia Increased blood pressure Tremulousness Seizures Ventricular tachycardia and fibrillation Pulmonary edema Cardiac arrest The drug is likely to produce withdrawal symptoms These reactions will not occur with everyone and will vary with individuals. Adverse Reactions

http://harmreduction.org/issues/overdose-prevention/overview/overdose-basics/responding-to-opioid-overdose/administer-naloxone/ http://www.drugs.com/pro/naloxone.html http://www.medpagetoday.com/Psychiatry/Addictions/45164 http://www.evzio.com/hcp/ http://www.cdc.gov/homeandrecreationalsafety/overdose/facts.html http://stopoverdose.org/pharmacy.htm http://www.rxlist.com/narcan-drug.htm http://www.nlm.nih.gov/medlineplus/druginfo/meds/a612022.html References

This informational piece about Naloxone is designed in the form of a PowerPoint presentation to be presented to physicians and pharmacists within a health care clinic or a hospital. Specifically, those working in primary care, ambulatory care, outpatient services and pain management are the target audience. The audience needs a simple and professional presentation of the topic with information necessary to safely prescribe and dispense the product. The audience will encounter this presentation at work or a conference and it will be given by a pharmacist. Additionally, the pharmacists in attendance may receive law-mandated continuing education credits from attending the presentation. In designing this document, my primary goal was to create an informative presentation that is visually appealing, professional and straight to the point. Unit 2 Reflection